Tag - CytoDyn

Developments

CytoDyn files IND and Phase 2 protocol to treat NASH with leronlimab

CytoDyn (OTCQB:CYDY) filed an IND and a Phase 2 clinical trial protocol with the FDA for the treatment of non-alcoholic steatohepatitis (NASH) with its lead drug candidate, leronlimab. Based on published reports of the...

September 4, 2019

Developments

CytoDyn reports interim data from HIV leronlimab monotherapy trial

CytoDyn (OTCQB:CYDY) reported interim data from its dose-escalating trial of leronlimab monotherapy for the treatment of HIV. Leronlimab is humanized monoclonal antibody that targets CCR5, a receptor by which HIV enters...

August 14, 2019

Tag - CytoDyn

CytoDyn files IND and Phase 2 protocol to treat NASH with leronlimab

CytoDyn reports interim data from HIV leronlimab monotherapy trial

General

More